2021-04-30T07:00:24-07:00 2020-06-30 743216978 NAWROCKI SMITH LLP 290 BROADHOLLOW RD STE 115E MELVILLE NY 11747 990 2019-07-01 943342838 ANIMAL CANCER FOUNDATION ANIM 5168584960 191 MAIN STREET PORT WASHINGTON NY 11050 barbara cohen Executive Director 2021-04-30 true DAVID TELLIER P01359581 6317569500 2019 2022-09-23 18:48:47Z Barbara Cohen 301410 false X WWW.ACFOUNDATION.ORG X 1999 CA ACF develops and supports research that advances the prevention and treatment of cancer for people and pets. ACF focuses on furthering research in comparative oncology, which is the study of cancers that occur similarly in both companion animals and humans.To fund and develop research focused on the biologic similarity of cancer in pets and people that will expedite therapeutic and preventative benefits for both. Also, to inform the public and the scientific community about the biologic similarity of cancer in pets and people, and to communicate the ways in which comparative oncology will accelerate the treatment, prevention and ultimate eradication of cancer.The Canine Cancer Genome Project (CCGP) sponsored by Blue Buffalo Foundation and Animal Cancer Foundation seeks to map the seven most common canine cancer tumors and to place the datasets in the public domain for use by all cancer researchers. 4 4 3 20 0 837412 268277 0 13083 21691 713 11442 851208 301410 49282 52500 0 133486 167562 0 110209 190311 134240 373079 354302 478129 -52892 1418343 1342259 55928 40701 1362415 1301558 ACF DEVELOPS AND SUPPORTS RESEARCH THAT ADVANCES THE PREVENTION AND TREATMENT OF CANCER FOR PEOPLE AND PETS. ACF FOCUSES ON FURTHERING RESEARCH IN COMPARATIVE ONCOLOGY, WHICH IS THE STUDY OF CANCERS THAT OCCUR SIMILARLY IN BOTH PETS AND HUMANS. false false 180703 The Canine Cancer Genome Project ("CCGP") sponsored by Animal Cancer Foundation (Research Project) has seven canine cancer tumor types as catalogued by Canine Comparative Oncology and Genomics Consortium ("CCOGC") for canine cancer genomic research. The ACF board of directors represented by pro-bono legal counsel at Eversheds Sutherland entered contract negotiations with a genomics laboratory (Principal Investigator) recommended to it by a scientific advisory council of leaders in veterinary and human oncology. The principal investigators will lead under their own sub-contracted agreements a multi-disciplinary and multi-institutional group to conduct multi-platform genomic characterization of CCOGC cases and to prospectively collect additional samples for subsequent analysis in a separate research project to further enhance the existing research project generated canine cancer genome profiles. After being delayed by the COVID19 pandemic, contract negotiations resumed in early fall 2020 and a MASTER RESEARCH COLLABORATION AGREEMENT (the Agreement) was executed on February 22, 2021.ACF Comparative Oncology Grant Awards are annual research grants of $50,000 for comparative oncology research that provides near-term benefit to pets with cancer while offering possibilities of translation to human cancer research and treatment. The board of directors considers recommendations of the scientific advisory council, which solicits and meets to evaluate proposal. ACF enters grant agreements with the awarded institution and primary investigator prior to the award being made. The board of directors exercises its right to continue to support researchers whose work has been identified as qualified by the scientific advisory council.ACF conducts comparative oncology awareness campaigns (various) to provide information to the general public about the incidences of pet cancer, the similarities of human and canine cancer, ongoing research data in publication in the field of comparative oncology, and the need to develop robust science research in this area. Campaigns may be print, website, email, social media post, or participation at related events.ACF supports workshops, symposia and conferences furthering comparative oncology that have included the Veterinary Eastern Cooperative Oncology Group ("VECOG"), the Veterinary Cancer Society ("VCS") annual conference and the National Academies of Sciences Medicine. Many of these were postponed in 2020 due to the COVID19 pandemic. 180703 true true false false false false false false false false true false false false false false true false false false false false false false false false false true false false false false false false false false false false true false false false false false false false false true 8 0 false 3 true false false false false false false false 0 false false false false false false false X 4 4 false false false false false false false true true false false true true true true true false true false false CA NY X X X BARBARA COHEN 5168584960 191 MAIN STREET 225 PORT WASHINGTON NY 11050 X Barbara Cohen Executive Director 40.00 0.00 75423 0 0 Natasha Lunin Director 3.00 0.00 X 0 0 0 Gerald Post President 3.00 0.00 X X 0 0 0 Jonathan Peris Treasurer 3.00 0.00 X X 0 0 0 Jennifer Teitler Secretary 3.00 0.00 X X 0 0 0 75423 0 false false false 0 268277 5014 268277 0 21691 21691 0 0 0 0 0 0 0 Miscellaneous 11442 11442 11442 301410 21691 11442 52500 52500 0 0 0 75423 39967 9096 26360 0 80231 42514 9677 28040 0 0 11908 6310 1436 4162 0 0 18262 18262 0 0 0 34630 11146 12176 11308 37634 8761 150 28723 6302 2818 2585 899 13925 9279 4646 0 0 37 37 0 0 0 0 1061 743 318 6309 288 5831 190 Sponsorships 5325 5325 Printing and Publications 3457 772 1207 1478 LICENSE AND PERMITS 3390 461 2929 BANK FEES 2251 777 1474 1657 280 1377 354302 180703 63390 110209 1074581 1049296 46352 46907 0 69185 12898 0 0 0 0 2045 2453 1628 1628 0 224886 230472 0 0 0 1294 233 1418343 1342259 55928 6371 34330 55928 40701 X 363293 222939 999122 1078619 1362415 1301558 1418343 1342259 -52892 -7965 X false true X true false X 290101 689330 282555 837412 367712 2467110 0 0 290101 689330 282555 837412 367712 2467110 0 2467110 4189 4255 4353 9011 18391 40199 0 0 2507309 0.98400 0.98960 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1628 1628 455438 -7965 161993 154028 301410 301410 516295 161993 161993 354302 354302 false PEEL Therapeutics Inc 2000 Circle of Hope Drive Salt Lake City UT 84112 811890107 50000 0 FMV Cancer Research 0 1 X 1 5014 FMV X Legal Services 1 81787 FMV X Marketing Services 1 71840 FMV X Graphic Design 1 4000 FMV X Artist Services 1 3375 FMV X IT Services 1 455 FMV X Pet Sympathy CD 1 500 FMV X Raffle Gift 1 36 FMV false true false Form 990, Part VI, Line 11b: Form 990 Review Process THE 990 DRAFT IS PROVIDED TO EACH BOARD MEMBER FOR COMPLETE REVIEW PRIOR TO FILING. Form 990, Part VI, Line 12c: Explanation of Monitoring and Enforcement of Conflicts THE FOUNDATION MONITORS THEIR CONFLICT OF INTEREST POLICY AT THEIR BOARD MEETINGS. THE POLICY IS ENFORCED ON AN ONGOING BASIS. Form 990, Part VI, Line 15a: Compensation Review & Approval Process - CEO, Top Management THE FOUNDATION HAS THREE EMPLOYEES WHICH ARE THE EXECUTIVE DIRECTOR, THE DIRECTOR OF DEVELOPMENT, AND THE DIRECTOR OF MARKETING. THE BOARD MEETS ANNUALLY TO DISCUSS THE SALARY OF THE EXECUTIVE DIRECTOR. Form 990, Part VI, Line 19: Other Organization Documents Publicly Available ALL PUBLIC DOCUMENTS ARE MADE AVAILABLE UPON REQUEST AT THE FOUNDATION'S ADDRESS OF OPERATIONS, AS WELL AS ON THEIR WEBSITE